Product Information
DORZOLAMIDE HCL 2% EYE DROPS is a generic product labeled by Fosun Pharma USA Inc., priced at $0.8575 per ML under NDC 72266019701. Its NADAC has been published 146 times since Sep 13, 2023.
Strength
20 mg/mL
Manufacturer
Fosun Pharma USA Inc.NDC
72266019701
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215660On Market Since
1/23/2023
Pharmacological Classes
Price Statistics
The NADAC for DORZOLAMIDE HCL 2% EYE DROPS has been published 146 times since Sep 13, 2023, and over the history we have for it it has declined 34.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8575 per ML |
|---|---|
| All-time high | $1.5851 (Nov 13, 2024) |
| All-time low | $0.8554 (May 20, 2026) |
| 52-week high | $1.3114 |
| 52-week low | $0.8554 |
| Median price | $1.2714 |
| Average price | $1.1908 |
| Largest weekly change | +42.1% (Sep 18, 2024) |
| Weeks tracked | 146 |
| Tracking since | Sep 13, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DORZOLAMIDE HCL 2% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE HCL 2% EYE DROPS, manufactured by Fosun Pharma USA Inc., is $0.8575 per ML (NDC 72266019701), effective Jun 24, 2026.
How has the price of DORZOLAMIDE HCL 2% EYE DROPS changed over time?
Over the history we have for it, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has declined 34.2%. It has been tracked across 146 weekly CMS publications since Sep 13, 2023.
What are the highest and lowest recorded NADAC prices for DORZOLAMIDE HCL 2% EYE DROPS?
Since Sep 13, 2023, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has ranged from a low of $0.8554 (May 20, 2026) to a high of $1.5851 (Nov 13, 2024), with a median of $1.2714 per ML.
Are there cheaper alternatives to DORZOLAMIDE HCL 2% EYE DROPS?
3 NADAC-published products share the same active ingredient, strength, and dosage form as DORZOLAMIDE HCL 2% EYE DROPS, but none are currently priced below it.
Who manufactures DORZOLAMIDE HCL 2% EYE DROPS?
DORZOLAMIDE HCL 2% EYE DROPS (NDC 72266019701) is labeled by Fosun Pharma USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification